Shanelle R. Shillingford

Also affiliated with Summit Medical Group (United States), Boston Consulting Group (United States)

Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding”.

A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102617

N/A

0DataRank · unranked

11 citations

Lei Zhang, Yulia V. Surovtseva, Sam Dorry, Elias Lolis, Anton M. Bennett +1 more

Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114712

N/A

0DataRank · unranked

8 citations

Haya Jamali, Oh Sang Kweon, James Herrington, Shanelle R. Shillingford, Christina Papini +6 more

Dynamic and structural insights into allosteric regulation on MKP5 a dual-specificity phosphatase

Nature Communications(2025)10.1038/s41467-025-62150-w

N/A

0DataRank · unranked

2 citations

Federica Maschietto, R. Manjula, Shanelle R. Shillingford, James H. Murphy, Elias Lolis +4 more